A cluster of cystic fibrosis mutations in exon 17b of the CFTR gene: a site for rare mutations. 1994

B Mercier, and W Lissens, and G Novelli, and L Kalaydjieva, and M de Arce, and N Kapranov, and N Canki Klain, and X Estivill, and A Palacio, and S Cashman
Centre de Biogénétique, CDTS, Brest, France.

Intensive screening has improved our understanding of the profile of mutations in the CFTR gene in which more than 400 mutations have been detected to date. In collaboration with several European laboratories we are involved in such analysis. We have identified 14 new mutations in exon 17b of CFTR, having analysed 780 CF chromosomes, and have compared the frequency of mutations in this exon with that of other regions of the CFTR gene. The results obtained indicate an accumulation of mutations, not only in regions encoding the two nucleotide binding folds, but also in those encoding transmembrane domains of the CFTR gene, in particular exon 17b.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019005 Cystic Fibrosis Transmembrane Conductance Regulator A chloride channel that regulates secretion in many exocrine tissues. Abnormalities in the CFTR gene have been shown to cause cystic fibrosis. (Hum Genet 1994;93(4):364-8) CFTR Protein,Chloride channels, ATP-gated CFTR,Chloride channels, ATP gated CFTR,Protein, CFTR

Related Publications

B Mercier, and W Lissens, and G Novelli, and L Kalaydjieva, and M de Arce, and N Kapranov, and N Canki Klain, and X Estivill, and A Palacio, and S Cashman
January 1994, Human genetics,
B Mercier, and W Lissens, and G Novelli, and L Kalaydjieva, and M de Arce, and N Kapranov, and N Canki Klain, and X Estivill, and A Palacio, and S Cashman
April 1994, Human molecular genetics,
B Mercier, and W Lissens, and G Novelli, and L Kalaydjieva, and M de Arce, and N Kapranov, and N Canki Klain, and X Estivill, and A Palacio, and S Cashman
December 1991, American journal of human genetics,
B Mercier, and W Lissens, and G Novelli, and L Kalaydjieva, and M de Arce, and N Kapranov, and N Canki Klain, and X Estivill, and A Palacio, and S Cashman
December 1992, Human genetics,
B Mercier, and W Lissens, and G Novelli, and L Kalaydjieva, and M de Arce, and N Kapranov, and N Canki Klain, and X Estivill, and A Palacio, and S Cashman
September 2003, Clinical genetics,
B Mercier, and W Lissens, and G Novelli, and L Kalaydjieva, and M de Arce, and N Kapranov, and N Canki Klain, and X Estivill, and A Palacio, and S Cashman
January 1995, Wiener klinische Wochenschrift,
B Mercier, and W Lissens, and G Novelli, and L Kalaydjieva, and M de Arce, and N Kapranov, and N Canki Klain, and X Estivill, and A Palacio, and S Cashman
October 2013, Prescrire international,
B Mercier, and W Lissens, and G Novelli, and L Kalaydjieva, and M de Arce, and N Kapranov, and N Canki Klain, and X Estivill, and A Palacio, and S Cashman
April 1995, Human genetics,
B Mercier, and W Lissens, and G Novelli, and L Kalaydjieva, and M de Arce, and N Kapranov, and N Canki Klain, and X Estivill, and A Palacio, and S Cashman
January 1995, Revue de pneumologie clinique,
B Mercier, and W Lissens, and G Novelli, and L Kalaydjieva, and M de Arce, and N Kapranov, and N Canki Klain, and X Estivill, and A Palacio, and S Cashman
January 1992, Human genetics,
Copied contents to your clipboard!